Process View
The change in morphology and behavior of a mature or immature T cell resulting from exposure to an antigen for which its T cell receptor is specific bound to an MHC molecule on an antigen presenting cell, leading to the initiation or perpetuation of an immune response.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "t cell activation via t cell receptor contact with antigen bound to mhc molecule on antigen presenting cell"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 1.000 | ||
| LILRA6 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 | 0.987 | ||
| FHL2 | four and a half LIM domains 2 | 0.978 | ||
| LILRB1 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 | 0.782 | ||
| PILRA | paired immunoglobin-like type 2 receptor alpha | 0.626 | ||
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.567 | ||
| ENG | endoglin | 0.442 | ||
| LILRB2 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 | 0.407 | Human | |
| LILRA1 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1 | 0.323 | Human | |
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.273 | ||
| LILRA2 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 | 0.235 | ||
| ITGB2 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | 0.209 | ||
| SIGLEC7 | sialic acid binding Ig-like lectin 7 | 0.190 | ||
| PTAFR | platelet-activating factor receptor | 0.166 | ||
| HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.164 | ||
| LILRB3 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 | 0.151 | Human | |
| HLA-DMA | major histocompatibility complex, class II, DM alpha | 0.109 | ||
| FCN1 | ficolin (collagen/fibrinogen domain containing) 1 | 0.109 | ||
| PECAM1 | platelet/endothelial cell adhesion molecule | 0.098 | ||
| HK3 | hexokinase 3 (white cell) | 0.089 | ||
| CSK | c-src tyrosine kinase | 0.078 | ||
| HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 and major histocompatibility complex, class II, DR beta 1 | 0.075 | ||
| AOAH | acyloxyacyl hydrolase (neutrophil) | 0.062 | ||
| TLN1 | talin 1 | 0.062 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.060 | ||
| FHL3 | four and a half LIM domains 3 | 0.057 | ||
| MICA | MHC class I polypeptide-related sequence A | 0.056 | ||
| ITGAL | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | 0.053 | ||
| TYMP | thymidine phosphorylase | 0.051 | ||
| PTPRC | protein tyrosine phosphatase, receptor type, C | 0.049 | ||
| HCK | hemopoietic cell kinase | 0.047 | ||
| FN1 | fibronectin 1 | 0.045 | ||
| SELPLG | selectin P ligand | 0.043 | ||
| AIF1 | allograft inflammatory factor 1 | 0.039 | ||
| NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.036 | ||
| FLNA | filamin A, alpha | 0.035 | ||
| SPI1 | spleen focus forming virus (SFFV) proviral integration oncogene spi1 | 0.035 | ||
| CLEC4M | C-type lectin domain family 4, member M | 0.035 | ||
| LST1 | leukocyte specific transcript 1 | 0.034 | ||
| SLC11A1 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 | 0.034 | ||
| SIRPB1 | signal-regulatory protein beta 1 | 0.034 | ||
| EMR1 | egf-like module containing, mucin-like, hormone receptor-like 1 | 0.033 | ||
| TREM1 | triggering receptor expressed on myeloid cells 1 | 0.031 | ||
| GMFG | glia maturation factor, gamma | 0.031 | ||
| FCGR2C | Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene) | 0.031 | ||
| NLRP3 | NLR family, pyrin domain containing 3 | 0.031 | ||
| DPEP2 | dipeptidase 2 | 0.030 | ||
| CSF3R | colony stimulating factor 3 receptor (granulocyte) | 0.029 | ||
| CYTH4 | cytohesin 4 | 0.028 | ||
| PXN | paxillin | 0.027 | ||
| FCGR3B | Fc fragment of IgG, low affinity IIIb, receptor (CD16b) | 0.027 | ||
| SLC15A3 | solute carrier family 15, member 3 | 0.025 | ||
| IGSF6 | immunoglobulin superfamily, member 6 | 0.025 | ||
| SIGLEC9 | sialic acid binding Ig-like lectin 9 | 0.024 | ||
| SIRPA | signal-regulatory protein alpha | 0.024 | ||
| ACVRL1 | activin A receptor type II-like 1 | 0.023 | ||
| ITGAX | integrin, alpha X (complement component 3 receptor 4 subunit) | 0.023 | Human | |
| CD300A | CD300a molecule | 0.023 | ||
| MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.023 | ||
| CYBB | cytochrome b-245, beta polypeptide | 0.023 | ||
| FPR1 | formyl peptide receptor 1 | 0.023 | ||
| PLEK | pleckstrin | 0.022 | ||
| NOD2 | nucleotide-binding oligomerization domain containing 2 | 0.022 | ||
| PSEN2 | presenilin 2 (Alzheimer disease 4) | 0.021 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.021 | ||
| CD86 | CD86 molecule | 0.021 | ||
| VSIG4 | V-set and immunoglobulin domain containing 4 | 0.021 | ||
| LY86 | lymphocyte antigen 86 | 0.020 | ||
| PDIA3 | protein disulfide isomerase family A, member 3 | 0.020 | ||
| TLR8 | toll-like receptor 8 | 0.020 | ||
| HSD3B7 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 | 0.020 | ||
| ITGA6 | integrin, alpha 6 | 0.020 | ||
| ITGB4 | integrin, beta 4 | 0.019 | ||
| NCKAP1L | NCK-associated protein 1-like | 0.019 | ||
| THBS1 | thrombospondin 1 | 0.019 | ||
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.019 | ||
| LILRA3 | leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3 | 0.018 | Human | |
| SNCA | synuclein, alpha (non A4 component of amyloid precursor) | 0.018 | ||
| FCAR | Fc fragment of IgA, receptor for | 0.018 | Human | |
| CR1 | complement component (3b/4b) receptor 1 (Knops blood group) | 0.018 | ||
| LILRA5 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 | 0.018 | Human | |
| IL2RA | interleukin 2 receptor, alpha | 0.018 | ||
| CD22 | CD22 molecule | 0.018 | ||
| CD14 | CD14 molecule | 0.018 | ||
| RASSF4 | Ras association (RalGDS/AF-6) domain family member 4 | 0.017 | ||
| MARCO | macrophage receptor with collagenous structure | 0.017 | ||
| PTPN2 | protein tyrosine phosphatase, non-receptor type 2 | 0.017 | ||
| CD163 | CD163 molecule | 0.017 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.017 | ||
| LAIR1 | leukocyte-associated immunoglobulin-like receptor 1 | 0.016 | Human | |
| SHARPIN | SHANK-associated RH domain interactor | 0.016 | ||
| CD1D | CD1d molecule | 0.016 | ||
| CD63 | CD63 molecule | 0.016 | ||
| PIK3R5 | phosphoinositide-3-kinase, regulatory subunit 5 | 0.016 | ||
| BIN2 | bridging integrator 2 | 0.016 | ||
| HLA-G | major histocompatibility complex, class I, G | 0.016 | ||
| LCP1 | lymphocyte cytosolic protein 1 (L-plastin) | 0.016 | ||
| CASP5 | caspase 5, apoptosis-related cysteine peptidase | 0.016 | ||
| LILRB4 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4 | 0.016 | Human | |
| CD52 | CD52 molecule | 0.016 | ||
| S100A9 | S100 calcium binding protein A9 | 0.015 | ||
| CD180 | CD180 molecule | 0.015 | ||
| AQP9 | aquaporin 9 | 0.015 | ||
| C3AR1 | complement component 3a receptor 1 | 0.015 | ||
| CMKLR1 | chemokine-like receptor 1 | 0.015 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.015 | ||
| RAC2 | ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) | 0.015 | ||
| FMNL1 | formin-like 1 | 0.015 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.014 | ||
| CD300C | CD300c molecule | 0.014 | ||
| LGALS1 | lectin, galactoside-binding, soluble, 1 | 0.014 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.014 | ||
| ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | 0.014 | Human | |
| FPR2 | formyl peptide receptor 2 | 0.014 | ||
| MS4A4A | membrane-spanning 4-domains, subfamily A, member 4 | 0.014 | ||
| ITGA7 | integrin, alpha 7 | 0.014 | Human | |
| S100A12 | S100 calcium binding protein A12 | 0.014 | ||
| VNN2 | vanin 2 | 0.014 | ||
| CFP | complement factor properdin | 0.014 | ||
| ITGAM | integrin, alpha M (complement component 3 receptor 3 subunit) | 0.014 | Human | |
| FOLR3 | folate receptor 3 (gamma) | 0.014 | ||
| NCF2 | neutrophil cytosolic factor 2 | 0.013 | ||
| BEST1 | bestrophin 1 | 0.013 | ||
| CD33 | CD33 molecule | 0.013 | ||
| CSF1R | colony stimulating factor 1 receptor | 0.013 | ||
| ASGR2 | asialoglycoprotein receptor 2 | 0.013 | ||
| SERPINA1 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 | 0.013 | ||
| HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 | 0.013 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.013 | ||
| CD37 | CD37 molecule | 0.013 | ||
| CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | 0.013 | ||
| APOBR | apolipoprotein B receptor | 0.013 | ||
| SLC7A7 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 7 | 0.013 | ||
| HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 | 0.012 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.012 | ||
| IL1B | interleukin 1, beta | 0.012 | ||
| STAB1 | stabilin 1 | 0.012 | ||
| SIGLEC5 | sialic acid binding Ig-like lectin 5 | 0.012 | ||
| SEMA4D | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D | 0.012 | ||
| ARHGAP25 | Rho GTPase activating protein 25 | 0.012 | ||
| CD72 | CD72 molecule | 0.012 | ||
| AR | androgen receptor | 0.012 | ||
| TMSB4X | thymosin beta 4, X-linked | 0.012 | ||
| C1orf38 | chromosome 1 open reading frame 38 | 0.012 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.012 | ||
| IL16 | interleukin 16 (lymphocyte chemoattractant factor) | 0.012 | ||
| TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.012 | ||
| HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.012 | ||
| ITGB7 | integrin, beta 7 | 0.012 | ||
| NFE2 | nuclear factor (erythroid-derived 2), 45kDa | 0.012 | ||
| LRMP | lymphoid-restricted membrane protein | 0.012 | ||
| TMC8 | transmembrane channel-like 8 | 0.012 | ||
| CD68 | CD68 molecule | 0.012 | ||
| SLAMF7 | SLAM family member 7 | 0.012 | ||
| CEACAM3 | carcinoembryonic antigen-related cell adhesion molecule 3 | 0.012 | ||
| NPNT | nephronectin | 0.011 | ||
| P2RX1 | purinergic receptor P2X, ligand-gated ion channel, 1 | 0.011 | ||
| IFNGR2 | interferon gamma receptor 2 (interferon gamma transducer 1) | 0.011 | ||
| SLAMF8 | SLAM family member 8 | 0.011 | ||
| C17orf60 | chromosome 17 open reading frame 60 | 0.011 | ||
| CYTH1 | cytohesin 1 | 0.011 | ||
| HAMP | hepcidin antimicrobial peptide | 0.011 | ||
| VNN1 | vanin 1 | 0.011 | ||
| TBXAS1 | thromboxane A synthase 1 (platelet) | 0.011 | ||
| CLEC5A | C-type lectin domain family 5, member A | 0.011 | ||
| ICAM2 | intercellular adhesion molecule 2 | 0.011 | Human | |
| CLEC10A | C-type lectin domain family 10, member A | 0.011 | ||
| GPR132 | G protein-coupled receptor 132 | 0.011 | ||
| EPOR | erythropoietin receptor | 0.011 | ||
| CTGF | connective tissue growth factor | 0.011 | ||
| EVI2A | ecotropic viral integration site 2A | 0.010 | ||
| IKZF1 | IKAROS family zinc finger 1 (Ikaros) | 0.010 | ||
| CFD | complement factor D (adipsin) | 0.010 | ||
| FES | feline sarcoma oncogene | 0.010 | ||
| HLA-DPB1 | major histocompatibility complex, class II, DP beta 1 | 0.010 | ||
| SPHK1 | sphingosine kinase 1 | 0.010 | ||
| MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.010 | ||
| TLR6 | toll-like receptor 6 | 0.010 | ||
| CD80 | CD80 molecule | 0.010 | ||
| TFEB | transcription factor EB | 0.010 | ||
| ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.010 | ||
| RNASE3 | ribonuclease, RNase A family, 3 | 0.010 | ||
| MMP19 | matrix metallopeptidase 19 | 0.010 | ||
| SIPA1 | signal-induced proliferation-associated 1 | 0.010 | ||
| F5 | coagulation factor V (proaccelerin, labile factor) | 0.010 |